Trademarkia Logo

Canada

C$
CLAYAUTHO
REGISTERED

on 16 May 2025

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

55218 Ingelheim

DE

Serial Number

2225372 filed on 14th Oct 2022

Registration Number

TMA1314218 registered on 16th May 2025

Registration expiry Date

14th Oct 2032

Correspondent Address

MARKS & CLERK

180 Kent StreetSuite 1900Ottawa

ONTARIO

CA

K1P0B6

CLAYAUTHO

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system and respiratory system; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases, namely viral infections.


Classification kind code

11

Mark Details


Serial Number

2225372

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 16th May 2025
Registration Pending
Submitted for opposition 55
on 16th May 2025
Registered
Submitted for opposition 252
on 16th May 2025
Statement of Grant of Protection Sent (following a Provisional Refusal)
Submitted for opposition 42
on 26th Feb 2025
Advertised
Submitted for opposition 222
on 26th Feb 2025
Opposition Start Date Notice Sent
Submitted for opposition 26
on 29th Jan 2025
Approved
Submitted for opposition 27
on 29th Jan 2025
Approval Notice Sent
Submitted for opposition 48
on 15th Jan 2025
Agent Changed
Submitted for opposition 20
on 8th Mar 2024
Examiner's First Report
Submitted for opposition 223
on 8th Mar 2024
Total Provisional Refusal